Detrol and Lialda drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Detrol (tolterodine tartrate) and Lialda (mesalamine). Common drug interactions include injection site bruising among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Detrol and Lialda. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Detrol?

Detrol has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 28,669 Detrol users. Check the latest studies of Detrol.

What is Lialda?

Lialda has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 10,199 Lialda users. Check the latest studies of Lialda.

On Jul, 22, 2026

11 people who take Detrol and Lialda together, and have interactions are studied.

What are the common drug interactions of Detrol and Lialda, by gender? *:

female:

Injection site bruising
Constipation
Drug administration error
Faecaloma (hard mass of fecal matter)
Headache (pain in head)
Injection site erythema (redness at injection site)
Injection site pain
Injection site papule (solid pimple or swelling at injection site)
Injection site pruritus (severe itching at injection site)
Injection site urticaria (rash of round, red welts on the skin at injection site)

male:

Abdominal distension
Asthenia (weakness)
Ocular hyperaemia (an abnormally large amount of blood in eye)
Platelet count decreased
Post procedural complication
Pyrexia (fever)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Somnolence (a state of near-sleep, a strong desire for sleep)
Brain neoplasm (tumour of brain)
Cataract (clouding of the lens inside the eye)

What are the common drug interactions of Detrol and Lialda, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Injection site bruising
Injection site erythema (redness at injection site)
Injection site papule (solid pimple or swelling at injection site)
Injection site pruritus (severe itching at injection site)

40-49:

Injection site pain
Injection site urticaria (rash of round, red welts on the skin at injection site)

50-59:

n/a

60+:

Headache (pain in head)
Abdominal distension
Feeding disorder (when children refuse to eat certain food groups)
Hypersomnia (excessive daytime sleepiness (eds))
Hypertension (high blood pressure)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Ocular hyperaemia (an abnormally large amount of blood in eye)
Platelet count decreased
Post procedural complication
Pyrexia (fever)

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 45.45%
Thyroid Diseases: 2 people, 18.18%
Impaired Gastric Emptying: 2 people, 18.18%
Bladder Disorder: 2 people, 18.18%
Cystitis Interstitial (unknown cause characterized by bladder pain): 2 people, 18.18%
Depression: 2 people, 18.18%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
Stress And Anxiety: 2 people, 18.18%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 18.18%
Laxative Supportive Care: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Detrol and Lialda?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously